GWM
ELV icon

Geneos Wealth Management’s Elevance Health ELV Stock Holding History

Geneos Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.63M Sell
19,237
-784
-4% -$258K 0.13% 189
2025
Q4 		$7.02M Sell
20,021
-157
-0.8% -$53.1K 0.17% 147
2025
Q3 		$6.52M Sell
20,178
-11,182
-36% -$3.48M 0.17% 154
2025
Q2 		$12.2M Sell
31,360
-25,834
-45% -$10.4M 0.3% 79
2025
Q1 		$24.9M Buy
57,194
+33,872
+145% +$13.6M 0.36% 63
2024
Q4 		$8.6M Buy
23,322
+1,853
+9% +$775K 0.3% 71
2024
Q3 		$11.2M Buy
21,469
+782
+4% +$418K 0.43% 48
2024
Q2 		$11.2M Buy
20,687
+121
+0.6% +$64K 0.5% 43
2024
Q1 		$10.7M Buy
20,566
+545
+3% +$271K 0.49% 44
2023
Q4 		$9.44M Sell
20,021
-1,078
-5% -$498K 0.47% 47
2023
Q3 		$9.19M Buy
21,099
+1,358
+7% +$616K 0.47% 41
2023
Q2 		$8.77M Buy
19,741
+3,786
+24% +$1.75M 0.46% 41
2023
Q1 		$7.34M Sell
15,955
-3,768
-19% -$1.79M 0.45% 42
2022
Q4 		$10.1M Sell
19,723
-2,484
-11% -$1.26M 0.61% 27
2022
Q3 		$10.1M Sell
22,207
-2,210
-9% -$1.06M 0.69% 21
2022
Q2 		$11.9M Sell
24,417
-367
-1% -$182K 0.59% 31
2022
Q1 		$12.2M Buy
24,784
+2,642
+12% +$1.21M 0.52% 35
2021
Q4 		$10.3M Sell
22,142
-160
-0.7% -$67.3K 0.39% 50
2021
Q3 		$8.39M Buy
22,302
+1,393
+7% +$529K 0.32% 60
2021
Q2 		$8.1M Sell
20,909
-1,160
-5% -$443K 0.32% 66
2021
Q1 		$8.37M Sell
22,069
-590
-3% -$190K 0.23% 100
2020
Q4 		$8.34M Buy
22,659
+2,258
+11% +$693K 0.33% 66
2020
Q3 		$5.21M Buy
20,401
+1,875
+10% +$505K 0.27% 85
2020
Q2 		$4.74M Buy
18,526
+3,362
+22% +$897K 0.26% 90
2020
Q1 		$3.38M Buy
15,164
+1,105
+8% +$301K 0.23% 105
2019
Q4 		$4.31M Buy
14,059
+1,116
+9% +$307K 0.23% 119
2019
Q3 		$3.08M Buy
12,943
+819
+7% +$224K 0.18% 138
2019
Q2 		$3.43M Buy
12,124
+172
+1% +$47K 0.21% 118
2019
Q1 		$3.43M Sell
11,952
-1,420
-11% -$411K 0.23% 117
2018
Q4 		$3.48M Sell
13,372
-482
-3% -$133K 0.26% 105
2018
Q3 		$3.8M Buy
13,854
+1,453
+12% +$377K 0.25% 116
2018
Q2 		$2.95M Buy
12,401
+1,115
+10% +$258K 0.23% 113
2018
Q1 		$2.48M Buy
11,286
+646
+6% +$152K 0.22% 118
2017
Q4 		$2.39M Buy
10,640
+469
+5% +$99.9K 0.21% 120
2017
Q3 		$1.94M Buy
10,171
+672
+7% +$128K 0.19% 131
2017
Q2 		$1.79M Buy
9,499
+1,482
+18% +$266K 0.18% 126
2017
Q1 		$1.34M Buy
8,017
+616
+8% +$98K 0.14% 144
2016
Q4 		$1.06M Buy
7,401
+217
+3% +$29.1K 0.14% 154
2016
Q3 		$900K Buy
7,184
+145
+2% +$18.7K 0.12% 171
2016
Q2 		$926K Sell
7,039
-423
-6% -$57.9K 0.13% 159
2016
Q1 		$1.06M Buy
+7,462
New +$997K 0.16% 144

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geneos Wealth Management's ELV Position: Q1 2026 in Review

Geneos Wealth Management reduced its Elevance Health (ELV) stake by 3.9% in Q1 2026, selling an estimated $258K and leaving 19,237 shares worth $5.63M. The position accounts for 0.13% of the portfolio, ranked #189.

Geneos Wealth Management first reported a position in ELV in Q1 2016 and has held it in 41 quarters since. The position peaked at $24.9M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Geneos Wealth Management held 19,237 shares of Elevance Health worth $5.63M as of Q1 2026.
  • Geneos Wealth Management sold 784 Elevance Health shares in Q1 2026, an estimated $258K.
  • Elevance Health made up 0.13% of Geneos Wealth Management's portfolio in Q1 2026, its #189 holding.
  • Geneos Wealth Management first reported a position in Elevance Health in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Elevance Health position peaked at $24.9M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.